UPDATED Jun 02, 2024
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GTC | UK£0.09 | -4.0% | -32.1% | UK£6.1m | n/a | PS1.4x | E86.1% | 0% | Energy | ||
GKP | UK£1.43 | 4.1% | -0.3% | UK£316.8m | UK£1.53 | PS3.3x | E47.6% | 0% | Energy | ||
PFC | UK£0.10 | 0% | -85.3% | UK£54.7m | n/a | PE-0.1x | E115.4% | 0% | Energy | ||
SPSY | UK£2.60 | 6.1% | 57.6% | UK£124.3m | UK£3.51 | PE26.2x | E26.3% | 3.5% | Tech | ||
IDHC | US$0.31 | -0.5% | -23.6% | US$187.8m | n/a | PE17.4x | E27.9% | n/a | Healthcare | ||
TEAM | UK£0.17 | -8.3% | -59.8% | UK£6.5m | n/a | PS1.2x | E58.6% | n/a | Diversified Financials | ||
PHC | UK£0.058 | -1.7% | -40.1% | UK£19.6m | n/a | PS2.1x | E94.4% | n/a | Materials | ||
VEL | UK£0.39 | -2.5% | -26.0% | UK£20.6m | n/a | PS1.3x | E140.5% | 0% | Capital Goods | ||
AET | UK£0.60 | -0.3% | 129.4% | UK£132.0m | n/a | PB3.7x | E99.2% | n/a | Energy | ||
B90 | UK£0.034 | 0% | -56.8% | UK£14.9m | n/a | PS5.8x | E142.7% | 0% | Consumer Services | ||
JDG | UK£112.00 | -2.6% | 11.4% | UK£743.8m | UK£126.39 | PE78.3x | E25.3% | 0.8% | Capital Goods | ||
FSG | UK£4.74 | 6.8% | 11.0% | UK£549.2m | UK£5.95 | PE26.2x | E30.9% | 4.7% | Diversified Financials | ||
LSL | UK£3.20 | 0.6% | 23.1% | UK£328.6m | UK£3.69 | PE40.6x | E33.3% | 3.6% | Real Estate Management and Development | ||
MEX | UK£0.53 | -4.5% | -45.3% | UK£20.3m | UK£1.05 | PB7x | E79.5% | n/a | Consumer Services | ||
BKS | UK£1.76 | 1.7% | 52.4% | UK£117.1m | UK£2.60 | PE198.4x | E57.9% | 0% | Software | ||
EVOK | UK£0.90 | -0.9% | 28.6% | UK£404.2m | UK£1.31 | PB5.1x | E79.1% | 0% | Consumer Services | ||
DXRX | UK£1.33 | 3.9% | 45.6% | UK£111.9m | UK£1.68 | PS4.7x | E62.5% | n/a | Pharmaceuticals & Biotech | ||
EAAS | UK£0.063 | 3.3% | 38.9% | UK£24.2m | n/a | PS1.4x | E91.1% | n/a | Commercial Services | ||
ONC | UK£0.20 | -22.1% | -2.2% | UK£14.6m | n/a | PS12.7x | E107.2% | n/a | Pharmaceuticals & Biotech | ||
FUM | UK£0.37 | -3.7% | -11.5% | UK£112.6m | UK£1.26 | PS36.3x | E111.8% | n/a | Pharmaceuticals & Biotech | ||
FTC | UK£0.59 | 7.3% | 353.8% | UK£128.1m | n/a | PS7.8x | E133.3% | n/a | Tech | ||
LLAI | UK£0.19 | 0% | -55.3% | UK£5.8m | UK£2.20 | PS161.4x | E88.7% | n/a | Pharmaceuticals & Biotech | ||
KIST | UK£1.37 | 0.7% | -43.2% | UK£113.5m | UK£3.60 | PB1.6x | E96.3% | n/a | Energy | ||
TPFG | UK£4.05 | 2.5% | 30.6% | UK£252.4m | UK£4.96 | PE34.1x | E36.7% | 3.0% | Real Estate Management and Development |